Utility of transcranial ultrasound in predicting Alzheimer's disease risk
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
25298200
DOI
10.3233/jad-141803
PII: G31750416Q7118NH
Knihovny.cz E-zdroje
- Klíčová slova
- Alzheimer's disease, breath-holding test, cerebrovascular reserve capacity, minimal cognitive impairment, transcranial color coded duplex ultrasonography, transcranial doppler sonography,
- MeSH
- Alzheimerova nemoc diagnostické zobrazování patofyziologie MeSH
- kognitivní poruchy etiologie MeSH
- lidé MeSH
- mozkový krevní oběh fyziologie MeSH
- ultrasonografie dopplerovská transkraniální * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Alzheimer's disease (AD) is a progressive, neurodegenerative disease characterized by an increasing incidence. One of the pathologic processes that underlie this disorder is impairment of brain microvasculature. Transcranial ultrasound is a non-invasive examination of cerebral blood flow that can be employed as a simple and useful screening tool for assessing the vascular status of brain circulation in preclinical and clinical stages of AD. The objective of this review is to explore the utility of using a transcranial ultrasound to diagnose AD. With transcranial ultrasound, the most frequently studied parameters are cerebral blood flow velocities and pulsatility indices, cerebrovascular reserve capacity, and cerebral microembolization. On the basis of current knowledge, we recommend using as a transcranial Doppler sonography screening method of choice the assessment of cerebrovascular reserve capacity with breath-holding test.
Citace poskytuje Crossref.org